David Emerson Jorden Nuo Therapeutics, Inc. (AURX) insider trading activity

David Emerson Jorden is CEO/CFO of Nuo Therapeutics, Inc.. Currently has a direct ownership of 2.05 Million shares of AURX, which is worth approximately $4.32 Million. The most recent transaction as insider was on Jan 01, 2026, when has been sold 25,381 shares (Common Stock) at a price of $1.97 per share, resulting in proceeds of $50,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.05M

4.68% 3M change

3.6% 12M change

Total Value Held $4.32 Million

DAVID EMERSON JORDEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2026	SELL Payment of exercise price or tax liability	$50,000 $1.97 p/Share	25,381 Reduced 1.23%	2,046,374 Common Stock
Jan 01 2026	BUY Exercise of conversion of derivative security	$50,000 $0.4 p/Share	125,000 Added 5.69%	2,071,755 Common Stock
Nov 28 2025	SELL Open market or private sale	$300,000 $1.5 p/Share	200,000 Reduced 9.32%	1,946,755 Common Stock
Aug 01 2025	SELL Payment of exercise price or tax liability	$37,084 $1.74 p/Share	21,313 Reduced 0.98%	2,146,755 Common Stock
Aug 01 2025	BUY Exercise of conversion of derivative security	$77,084 $0.4 p/Share	192,710 Added 8.16%	2,168,068 Common Stock
Nov 09 2022	SELL Open market or private sale	$243,750 $1.5 p/Share	162,500 Reduced 7.6%	1,975,358 Common Stock
Apr 29 2022	BUY Grant, award, or other acquisition	$10,532 $1.0 p/Share	10,532 Added 0.49%	2,137,858 Common Stock

DEJ

David Emerson Jorden

CEO/CFO

Houston, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AURX shares.

Notify only if

Value

Insider Trading

Get notified when an Nuo Therapeutics, Inc. insider buys or sells AURX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nuo Therapeutics, Inc.

Track Activities on AURX

Account